control group:Basic treatment of Western medicine, plus 3 placebo capsules, 3 times a day, oral
Sponsors
Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine, Shanghai Minhang District Central Hospital
Conditions
Chronic obstructive pulmonary disease
Phase 4
A multicenter, randomized, double-blind, placebo-controlled trial for Tanreqing capsule in the treatment of acute exacerbation of mild to moderate COPD
Active, not recruitingITMCTR2000003143
Start: 2020-03-20Updated: 2023-02-20
A multicenter, randomized, double-blind, placebo-controlled trial for Tanreqing capsule in the treatment of acute exacerbation of mild to moderate COPD
Active, not recruitingChiCTR2000031080
Start: 2020-03-20Updated: 2020-03-23
A prospective, randomized, double-blind, placebo-controlled and multicenter trial for Tanreqing capsule in the treatment of patients with AECOPD with upper respiratory tract infection
RecruitingITMCTR2100005207
Start: 2020-03-20Updated: 2023-02-20
A prospective, randomized, double-blind, placebo-controlled and multicenter trial for Tanreqing capsule in the treatment of patients with AECOPD with upper respiratory tract infection
RecruitingChiCTR2100050978
Start: 2020-03-20Updated: 2022-05-16